PenderFund Capital Management »

Recro Pharma shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Recro Pharma shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $181k 123k 1.46

More positions owned by PenderFund Capital Management

Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Bandwidth Note 0.500% 4/0 (Principal)
Ssr Mining In Note 2.500% 4/0 (Principal)
Sangoma Technologies Corp Com New (SANG)
Novavax Note 5.000%12/1 Added (Principal)
Burford Cap Ord Shs (BUR)
PAR Technology Corporation (PAR)
Western Asset Emerging Mrkts Dbt Fnd (EMD)
Nuveen Div. Advantage Muni. Fund (NAD)
Nuveen Municipal Credit Com Sh Ben Int (NZF)
Cable One Note 1.125% 3/1 (Principal)
Docebo (DCBO)
Aviat Networks Com New (AVNW)
Nuveen Insured Tax-Free Adv Munici (NEA)

View all positions for PenderFund Capital Management

Top funds holding Recro Pharma

Skandinaviska Enskilda Banken AB
Northern Trust
PenderFund Capital Management
Dimension Capital Management Partners

View all funds holding Recro Pharma